Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses

Advances in Immunology

Volumn 62, Issue , 1996, Pages 131-166

  Hathcock, Karen S ^a   Hodes, Richard J ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; HLA B7 ANTIGEN; RECEPTOR PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELL INTERACTION; CLONAL ANERGY; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALIGNANT TRANSFORMATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REVIEW; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

EID: 0029953530     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (143)

1. Arpin, C., Dechanet, J., Van Kooten, C., Merville, P., Grouard, G., Briere, F., Banchereau, J., and Liu, Y. J. (1995). Generation of memory B cells and plasma cells in vitro. Science 268, 720-722.
2. August, A., and Dupont, B. (1993). CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int. Immunol. 6, 769-774.
3. August, A., Gibson, S., Kawakami, Y., Mills, G. B., and Dupont, B. (1994). CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Set. USA 91, 9347-9351.
4. Azuma, M., Yssel, H., Phillips, J. H., Spits, H., and Lanier, L. L. (1993a). Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177, 845-850.
5. Azuma, M, Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., and Somoza, C. (1993b). B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79.
6. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., van Kooten, C, Liu, Y. J., Rousset, F., and Saeland, S. (1994). The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
7. Berek, C, and Zieger, M. (1993). The maturation of the immune response. Immunol. Today 14, 400-404.
8. Bluestone, J. A. (1995). New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2, 555-559.
9. Boussiotis, V. A., Freeman, G. J., Gribben, J. G., Daley, J., Gray, G., and Nadler, L. M. (1993). Activated human B lymphocytes express three CTLA4 binding counter-receptors which costimulate T cell activation. Proc. Natl. Acad. Sci. USA 90, 11059-11063.
10. Bretscher, P. A., and Cohn, M. (1970). A theory of self discrimination. Science 169, 1042-1049.
11. Brunet, J. F., Denizot, F., Luciani, M. F., Roux-Dosseto, M., Suzan, M., Mattei, M. G., and Golstein, P. (1987). A new member of the immunoglobulin supergene family-CTLA4. Nature 328, 267-270.
12. Caux, C., Vanbervliet, B., Massacrier, C, Azuma, M., Okumura, K., Lanier, L. L., and Banchereau, J. (1994). B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180, 1841-1847.
13. Chen, C., Faherty, D. A., Gault, A., Connaughton, S. E., Powers, G. D., Godfrey, D. I., and Nabavi, N. (1994a). Monoclonal antibody 2D10 recognizes a novel costimulatory molecule on activated murine B lymphocytes. J. Immunol. 152, 2105-2114.
14. Chen, C, Gault, A., Shen, L., and Nabavi, N. (1994b). Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B 7 - 2. J. Immunol. 152, 4929-4936.
15. Chen, C, and Nabavi, N. (1994). In vitro induction of T cell anergy by blocking B7 and early cell costimulatory molecule ETC/B7-2. Immunity 1, 147-154.
16. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, andlinsley, P. S. (1992). Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102.
17. Clark, E. A., and Ledbetter, J. A. (1994). How B and T cells talk to each other. Nature 367, 425-428.
18. Corry, D. B., Reiner, S. L., Linsley, P. S., and Locksley, R. M. (1994). Differential effects of blockade of CD28-B7 on the development of Thl or Th2 effector cells in experimental Leishmaniasis. J. Immunol. 153, 4142-4148.
19. Cross, A. H., Girard, T. J., Giacoletto, K. S., Evans, R. J., Keeling, R. M., Lin, R. F., Trotter, J. L., and Karr, R. W. (1995). Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J. Clin. Invest. 95, 2783-2789.
20. Damle, N. K., Mohagheghpour, N., Hansen, J. A., and Engleman, E. G. (1983). Alloantigenspeciflc cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct p r e c u r s o r s. J. Immunol. 131, 2296-3300.
21. Damle, N. K., Linsley, P. S., and Ledbetter, J. A. (1991). Direct helper T cell-induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7. Eur. J. Immunol. 21, 1277-1282.
22. Damle, N. K., Klussman, K., Leytze, G., Myrdal, S., Aruffo, A., Ledbetter, J. A., and Linsley, P. S. (1994). Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J. Immunol. 152, 2686-2697.
23. Das, M. R. P., Zamvil, S. S., Borriello, F., Weiner, H. L., Sharpe, A. H., and Kuchroo, V. K. (1995). Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur. J. Immunol. 25, 207-211.
24. de Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P., and Ceuppens, J. L. (1993). Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23, 3120-3125.
25. Fink, B. K., Linsley, P. S., and Wofsy, D. (1994). Treatment of murine lupus with CTLA4Ig. Science 265, 1225-1227.
26. Freedman, A. S., Freeman, G., Horowitz, J. C., Daley, J., and Nadler, L. M. (1987). B7, a B cell-restricted antigen that identifies preactivated B cells. J. Immunol. 139, 3260-3267.
27. Freedman, A. S., Freeman, G. J., Rhynhart, K., and Nadler, L. M. (1991). Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation. Cell. Immunol. 137, 429-437.
28. Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F., and Nadler, L. M. (1989). B7, a new member of the Ig superfamily with unique expression on activated and neoplasic B cells. J. Immunol. 143, 2714-2722.
29. Freeman, G. J., Gray, G. S., Gimmi, C. D., Lombard, D. B., Zhou, L. J., White, M., Fingeroth, J. D., Gribben, J. G., and Nadler, L. M. (1991). Structure, expression, and T cell eostimulatory activity of the murine homologue of the human B lymphocyte activation antigen B 7. J. Exp. Med. 174, 625-631.
30. Freeman, G. J., Lombard, D. B., Gimmi, C. D., Brod, S. A., Lee, K., Laning, J. C., Hafler, D. A., Dorf, M. E., Reiser, H., June, C. H., Thompson, C. B., and Nadler, L. M. (1992). CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 an CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 149
31. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G. L., McKnight, A. J., Kim, J., Du, L., Lombard, D. B., Gray, G. S., Nadler, L. M, and Sharpe, A. H. (1993a). Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262, 907-909.
32. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Jr., Lombard, L. A., Gray, G. S., and Nadler, L. M. (1993b). Cloning of B7-2: A CTLA-4 counterreceptor that costimulates human T cell proliferation. Science 262, 909-911.
33. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., Kim, J., Goldberg, J. M., Hathcock, K., Laszlo, G., Lombard, L. A., Wang, S., Gray, G. S., Nadler, L. M., and Sharpe, A. H. (1993c). Murine B7-2, an alternative CTLA-4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178,2185-2192.
34. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X. Y., Rennert, P. D., Gray, G. S., Gribben, J. G., and Nadler, L. M. (1995). B7-1 and B7-2 do not deliver identical eostimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
35. Fuller, K. A., Kanagawa, O., and Nahm, M. H. (1993), T cells within germinal centers are specific for the immunizing a n t i g e n. J. Immunol. 151, 4505-4512.
36. Galvin, F., Freeman, G. J., Razi-Wolf, Z., Hall, W., Jr., Benacerraf, B., Nadler, L., and Reiser, H. (1992). Murine B7 antigen provides a sufficient eostimulatory signal for antigen-specific and MHC-restricted T cell activation. J. Immunol. 149, 3802-3808.
37. Gimrni, C., Freeman, G., Gribben, J., Sugita, K., Freedman, A. S., Morimoto, C., and Nadler, L. (1991). B cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88,6575-6579.
38. Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G., Bluestone, J. A., and Thompson, C. B. (1994). Absence of B7-dependent responses in CD28-deficient mice. Immunity 1, 501-508.
39. Gross, J. A., Calks, E., and Allison, J. P. (1992). Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149, 380-388.
40. Guinan, E. C., Gribben, J. G., Boussiotis, V. A., Freeman, G. J., and Nadler, L. M. (1994). Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84, 3261-3282.
41. + T cells from human immunodeficiency virus type 1-infected donors. Proc. Natl. Acad. Sci. USA 90, 11094-11098.
42. Han, S., Hathcock, K., Zheng, B., Kepler, T. B., Hodes, R., and Kelsoe, G. (1995). Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal c e n t e r s. J. Immunol. 155, 556-567.
43. Harding, F. A., McArthur, J. G., Grossi, J. A., Raulet, D. H., and Allison, J. P. (1992). CD28-mediated signalling co-stimulates murine T cells and prevents induction of energy in T-cell clones. Nature 356, 607-609.
44. Harlan, D. M., Hengartner, H., Huang, M. L., Kang, Y. H., Abe, R., Moreadith, R. W., Pircher, H., Gray, G. S., Ohashi, P. S., Freeman, G. J., Nadler, L. M., June, C. H., and Aichele, P. (1994). Transgenic mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA 91, 3137-3141.
45. Harlan, D. M., Abe, R., Lee, K. P., and June, C. H. (1995). Potential roles of the B7 and CD28 receptor families in autoimmunity and immune invasion. Clin. Immunol. Immunopathol. 75, 99-111.
46. Harper, K., Balzano, C., Rouvier, E., Mattei, M. G., Luciani, M. F., and Golstein, P. (1991). CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147, 1037-1044.
47. Hathcock, K. S., Laszlo, G. L., Dickler, H. B., Bradshaw, J., Linsley, P., and Hodes, R. J. (1993). Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262, 905-907.
48. Hathcock, K. S., Laszlo, G.L., Pucillo, C. P., Linsley, P., and Hodes, R. J. (1994). Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and f u n c t i o n. J. Exp. Med. 180, 631-640.
49. Hutchcroft, J. E., and Bierer, B. E. (1994). Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins. Proc. Natl. Acad. Sci. USA 91, 3260-3264.
50. Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., Muramatsu, S., Hodes, R. J., and Steinman, R. M. (1994). The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180, 1849-1860.
51. Jacob, J., Kelsoe, G., Rajewsky, K., and Weiss, U. (1991a). Intraclonal generation of antibody mutants in germinal centers. Nature 354, 389-392.
52. Jacob, J., Kassir, R., and Kelsoe, G. (1991b). In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp. Med. 173, 1165-1175.
53. Jacob, J., and Kelsoe, G. (1992). In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)-acetyl. II. A common clonal origen for PALS-associated foci and germinal centers. J. Exp. Med. 176, 679-687.
54. Jacob, J., Miller, C., and Kelsoe, G. (1992). In situ studies of the antigen-driven somatic hypermutation of immunoglobulin genes. Immunol. Cell Biol. 70, 145-5152.
55. Jenkins, M. K., and Schwartz, R. H. (1987). Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vino. J. Exp. Med. 165, 302-319.
56. Jenkins, M. K., Ashwell, J. D., and Schwartz, R. H. (1988). Allogeneic non-T spleen cells stimulated with antigen and chemically modified antigen-presenting cells. J. Immunol. 140, 3324-3330.
57. Jenkins, M. K., Taylor, S. P., Norton, S. D., and Urdahl, K. B. (1991). CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147, 2461-2466.
58. June, C. H., Ledbetter, J. A., Linsley, P. S., and Thompson, C. B. (1990). Role of the CD28 receptor in T cell activation. Immunol. Today 11, 211-216.
59. June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B. (1994). The B7 and CD28 receptor families. Immunol. Today 15, 321-331.
60. Kelsoe, G. (1994). B cell diversification and differentiation in the periphery. J. Exp. Med. 180, 5-6.
61. Klaus, S. J., Pinchuk, L. M., Ochs, H. D., Law, C. L., Fanslow, W. C, Armitage, R. J., and Clark, E. A. (1994). Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152, 5643-5652.
62. + T cells. J. Exp. Med. 173,759-762.
63. Kozbor, D., Moretta, A., Messner, H. A., Moretta, L., and Croce, C. M. (1987). Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. J. Immunol. 138, 4128-4132.
64. Krummel, M. F., and Allison, J. P. (1995). CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465.
65. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M, Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., and Glimcher, L. H. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Thl/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707-718.
66. Kuiper, H. M., Brouwer, M., Linsley, P. S., and van Lier, R. A. W. (1995). Activated T cells can induce high levels of CTLA-4 expression on B cells. J. Immunol. 155,1776-1783.
67. + T cells. J. Exp. Med. 179, 819-830.
68. Lanier, L. L., O'Fallon, S., Somoza, C., Phillips, J. H., Linsley, P. S., Okumura, K., Ito, D., and Azuma, M. (1995). CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of C T L. J. Immunol. 154, 97-105.
69. Larsen, C. P., Ritchie, S. C, Pearson, T. C, Linsley, P. S., and Lowry, R. P. (1992). Functional expression of the costimulatory molecule, B7/BB1 on murine dendritic cell populations. J. Exp. Med. 176, 1215-1220.
70. Larsen, C. P., Ritchie, S. C, Hendrix, R., Linsley, P. S., Hathcock, K. S., Hodes, R. J., Lowry, R. P., and Pearson, T. C. (1994). Regulation of immunostimulatory function and costimulatory function molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152, 520
71. Ledbetter, J. A., Martin, P. J., Spooner, C. E., Wofsy, D., Tsu, T. T., Beatty, P. G., and Gladstone, P. (1985). Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J. Immunol. 135, 2331-2336.
72. Ledbetter, J. A., Parsons, M., Martin, P. J., Hansen, J. A., Rabinovitch, P. S., and June, C. H. (1986). Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: Effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppress i o n. J. Immunol. 137, 3299-3305.
73. Ledbetter, J. A., Imboden, J. B., Schieven, G. L., Grosmaire, L. S., Rabinovitch, P. S,, Lindsten, T., Thompson, C. B., and June, C. H. (1990). CD28 ligation in T-cell activation: Evidence for two signal transduction pathways. Blood 75, 1531-1538.
74. Ledbetter, J. A., and Linsley, P. S. (1992). CD28 receptor crosslinking induces tyrosine phosphorylation of PLCγ. In "Advances in Experimental Medical Biology" (S. Gupta and T. A. Waldman, Eds.), Vol. 323, pp. 23-27. Plenum Press, New York.
75. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., and Bluestone, J. A. (1992). Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257, 789-795.
76. Lenschow, D. J., Su, G. H. T., Zuckerman, L. A., Nabavi, N., Jellis, C. L., Gray, G. S., Miller, J., and Bluestone, J. A. (1993). Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA 90, 11054-11058.
77. Lenschow, D. J., Sperling, A. I., Cooke, M. P., Freeman, G., Rhee, L., Decker, D. C, Gray, G., Nadler, L. M., Goodnow, C. C., and Bluestone, J. A. (1994). Differential up-regulation of B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by a n t i g e n. J. Immunol. 153, 1990-1997.
78. Lenschow, D. J., Ho., S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herald, K. C., and Bluestone, J. A. (1995). Differential effects of anti-B7-l and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic m o u s e. J. Exp. Med. 181, 1145-1155.
79. + T cells and induce similar patterns of cytokine secretion in vitro. Int. Immunol. 7, 891-904.
80. Lin, H., Boiling, S. F., Linsley, P. S., Wei, R. Q., Gordon, D., Thompson, C. B., and Turka, L. A. (1993). Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific t r a n s f u s i o n. J. Exp. Med. 178, 1801-1806.
81. Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., Gray, G. S., Thompson, C. B., and June, C. H. (1993). Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151, 3489-3499.
82. Linsley, P. S., Clarke, E. A., and Ledbetter, J. A. (1990). The cell antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen, B7/BB-1. Proc. Natl. Acad. Sci. USA 87, 5031-5035.
83. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., and Ledbetter, J. A. (1991a). Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J. Exp. Med. 173, 721-730.
84. Linsley, P. S., Brady, W., Umes, M., Grosmaire, N. K., and Ledbetter, J. A. (1991b). CTLA-4 is a second receptor for the B cell activation antigen B 7. J. Exp. Med. 174, 561-569.
85. Linsley, P. S., Green, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C., and Damle, N. K. (1992a). Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176, 1595-1604.
86. Linsley, P. S., Wallace, P. M, Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., and Tepper, M. A. (1992b). Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-795.
87. Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., and Peach, R. (1994). Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793-801.
88. Linsley, P. S., and Ledbetter, J. A. (1993). The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
89. Linsley, P. S. (1995). Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation. J. Exp. Med. 182, 289-292.
90. Liu, Y. J., Zhang, J., Lane, P. J., Chan, E. Y., and MacLennan, I. C. (1991). Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21, 2951-2962.
91. Lu, Y., Granelli-Piperno, A., Bjorndahl, J. M., Phillips, C. A., and Trevillyan, J. M. (1992). CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway. J. Immunol. 149, 24-29.
92. Lum, L. G., Orcutt-Thordarson, N., Seigneuret, M. C, and Hansen, J. A. (1982). In vitro regulation of immunoglobulin synthesis by T-cell subpopulations defined by a new human T-cell antigen (9.3). Cell. Immunol. 72, 122-129.
93. MacLennan, I. C. M. (1994). Germinal Centers. Annu. Rev. Immunol. 12, 117-139.
94. McArthur, J. G., and Raulet, D. H. (1993). CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J. Exp. Med. 178,1645-1653.
95. McHeyzer-Williams, M. G., McLean, M. J., Lalor, P. A., and Nossel, G. J. V. (1993). Antigen-driven B cell differentiation in vivo. J. Exp. Med. 175, 295-307.
96. Miller, C., Kelsoe, G., and Han, S. (1994). Lack of B7-2 expression in the germinal centers of aged mice. Aging Immunol. Infect. Dis. 5, 249-257.
97. H hypermutation is absent in the germinal centers of aged mice. J. Immunol. 155, 3377-3384.
98. Muraille, E., De Smedt, T., Thielemans, K., Urbain, J., Mosier, M., and Leo, O. (1995). Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. Cell. Immunol. 162, 315-320.
99. Nabavi, N., Freeman, G. J., Gault, A., Godfry, D., Nadler, L. M., and Glimcher, L. M. (1992). Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360, 266-268.
100. Nandi, D., Gross, J. A., and Allison, J. P. (1994). CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152, 3361-3369.
101. Nozawa, Y., Wachi, E., Tominaga, K., Abe, M., and Wakasa, H. (1993). A novel monoclonal antibody (FUN-1) identifies an activation antigen in cells of the B-cell lineage and Reed-Sternberg cells. J. Pathol. 169, 309-315.
102. Nunes,J., Bagnasco, M., Lopez, M.,Lipcey,C, Mawas, C., and Olive, D. (1991). Dissociation between early and late events in T cell activation mediated through CD28 surface molecule. Mol. Immunol. 28, 427-435.
103. Nunes, J., Klasen, S., Franco, M. D., Lipcey, C., Mawas, C., Bagnasco, M., and Olive, D. (1993). Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-speciflc phospholipase C activity. Biochem. J. 293, 835-842.
104. Pages, F., Ragueneau, M., Rottapel, R., Truneh, A., Nunes, J., Imbert, J., and Olive, D. (1994). Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling. Nature (London) 369, 327-329.
105. Pearson, T. C, Alexander, D. Z., Winn, K. J., Linsley, P. S., Lowry, R. P., and Larsen, C. P. (1994). Transplantation tolerance induced by CTLA4-Ig. Transplantation 57,1701-1706.
106. Prasad, K. V., Cai, Y. C, Raab, M., Duckworth, B., Cantley, L., Shoelson, S. E., and Rudd, C. E. (1994). T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA 91,2834-2838.
107. Ranheim, E. A., and Kipps, T. J. (1993). Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177,925-935.
108. Razi-Wolf, Z., Freeman, G. J., Galvin, F., Benacerraf, B., Nadler, L., and Reiser, H. (1992). Expression and function of the murine B7 antigen, the major eostimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA 89, 4210-4214.
109. Reiser, H., Freeman, G. J., Razi-Wolf, Z., Gimmi, C. D., Benacerraf, B., and Nadler, L. M. (1992). Murine B7 antigen provides an efficient eostimulatory signal for activation of murine lymphocytes via the T-cell receptor/CD3 complex. Proc. Natl. Acad. Sci. USA 89, 271-275.
110. Robey, E., and Allison, J. P. (1995). T-cell activation: Integration of signals from the antigen receptor and eostimulatory molecules. Immunol. Today 16, 306-310.
111. + T cells and defective antibody production in v i v o. J. Exp. Med. 179, 809-817.
112. Roy, M., Aruffo, A., Ledbetter, J., Linsley, P., Kehry, M., and Noelle, R. (1995). Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25, 596-603.
113. Sansom, D. M., and Hall, N. D. (1993). B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro. Eur. J. Immunol. 23, 295-298.
114. Sayegh, M. H., Akalin, E., Hancock, W. W., Russell, M. E., Carpenter, C. B., Linsley, P. S., and Turka, L. A. (1995). CD28-B7 blockade after alloantigenic challenge in vivo inhibits Thl cytokines but spares Th2. J. Exp. Med. 181, 1869-1874.
115. Schneider, H., Prasad, V. S., Shoelson, S. E., and Rudd, C. E. (1995). CTLA-4 binding to the lipid kinase phosphatidyl-inositol 3-kinase in T cells. J. Exp. Med. 181, 351-355.
116. Schwartz, R. H. (1992). Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71, 1065-1068.
117. + T cells. Annu. Rev. Immunol. 12, 635-673.
118. Sethna, M. P., van Parijs, L., Sharpe, A. H., Abbas, A. K., and Freeman, G. J. (1994). A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1,415-421.
119. Shahinian, A., Pfeffer, K., Lee, K. P., Kundig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., and Mak, T. W. (1993). Differential Tcell eostimulatory requirements in CD28-deficient mice. Science 261, 609-612.
120. Snapper, C. M., and Finkelman, F. D. (1993). Immunoglobulin class switching. In "Fundamental Immunology, Third Edition" (W. E. Paul, ed.), pp. 837-863. Raven Press, New York.
121. Snow, E. C, and Noelle, R. J. (1993). The role of direct cellular communication during the development of a humoral immune response. Adv. Cancer Res. 62, 241-266.
122. Stack, R. M., Lenschow, D. J., Gray, G. S., Bluestone, J. A., and Fitch, F. W. (1994). IL-4 treatment of small splenic B cells induces eostimulatory molecules B7-1 and B7-2. J. Immunol. 152, 5723-5733.
123. Stein, P. H., Fraser, J. D., and Weiss, A. (1994). The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3' kinase. Mol. Cell. Biol. 14, 3392-3402.
124. Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A., and Linsley, P. S. (1993). Induction of alloantigen-specific hypresonsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177, 165-173.
125. Tew, J. G., Kosco, M. H., Burton, G. F., and Szakal, A. K. (1990). Follicular dendritic cells as accessory cells. Immunol. Rev. 117, 185-211.
126. Thompson, C. B., Leiden, J. M., and June, C. J. (1989). CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Set. USA 86, 1333-1337.
127. Thompson, C. B. (1995). Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81, 979-982.
128. + T cells by B7-transfected melanoma cells. Science 259, 368-370.
129. Truitt, K. E., Hicks, C. M., and Imboden, J. B. (1994). Stimulation of CD28 triggers an association between CD28 and phophatidylinositol 3-kmase in Jurkat cells. J. Exp. Med. 179, 1071-1076.
130. Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S., Gordon, D., Bailey, T., Boiling, S. F., and Thompson, C. B. (1992). T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89, 11102-11105.
131. Valle, A., Garrone, P., Yssel, H., Bonnefoy, J. Y., Freedman, A. S., Freeman, G., Nadler, L. M., and Banchereau, J. (1990). Mab 104 a new monoclonal antibody, recognizes the B7 antigen which is expressed on activated B cells and HTLV-1 transformed T cells. Immunology 69, 531-535.
132. Valle, A., Aubry, J.-P., Durand, I., and Banchereau, J. (1991). IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: An amplification mechanism for T-B cell interactions. Int. Immunol. 3, 229-235.
133. Vandenberghe, P., Freeman, G. J., Nadler, L. M., Fletcher, M. C, Lamoun, M., Turka, L. A., Ledbetter, J. A., Thompson, C. B., and June C. H. (1992). Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells. J. Exp. Med. 175, 951-960.
134. Vandenberghe, P., Delable, J., de Boer, M., De Wolf-Peeters, C., and Ceuppens, J. L. (1993). In situ expression of B7-BB1 on antigen presenting cells and activated B cells: An immunohistochemical study. Int. Immunol. 5, 317-321.
135. Van den Eertwegh, A. J. M., Noelle, R. J., Roy, M., Shepherd, D. M., Aruffo, A., Ledbetter, J. A., Boersma, W. J. A., and Claassen, E. (1994). In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med. 178, 1555-1565.
136. Van Gool, S. W., de Boer, M., and Ceuppens, J. L. (1994). The combination of anti-B7 monoclonal antibody and Cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction. J. Exp. Med. 179, 715-720.
137. Wallace, P. M., Rodgers, J. N., Leytze, G. M., Johnson, J. S., and Linsley, P. S. (1995). Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment. J. Immunol. 154, 5885-5895.
138. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., and Bluestone, J. A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
139. Ward, S. G., Westwick, J., Hall, N. D., and Sansom, D. M. (1993). Ligation of CD28 receptor by B7 induces formation of D-3 phosphotides in T lymphocytes independently of T cell receptor activation. Eur. J. Immunol. 23, 2572-2577.
140. Weiss, A., Manger, B., and Imboden, J. B. (1986). Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells. J. Immunol. 137, 819-825.
141. Yang, G., Hellstrom, K. E., Hellstrom, I., and Chen, L. (1995). Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol. 154, 2794-2880.
142. Yokochi, T., Holly, R. D., and Clark, E. A. (1982). B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J. Immunol. 128, 823-827.
143. Zheng, B., Xue, W., and Kelsoe, G. (1994). Locus-specific somatic hypermutation in germinal centre T cells. Nature 372, 556-559.